{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:27:20Z","timestamp":1791664040506,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["Several grants listed in detail in manuscript file"],"award-info":[{"award-number":["Several grants listed in detail in manuscript file"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00401-022-02419-2","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T14:04:09Z","timestamp":1649772249000},"page":"571-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-8734","authenticated-orcid":false,"given":"Vijay K.","family":"Ramanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Przybelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot J.","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Kosel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Machulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford R.","family":"Jack Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"2419_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"FE Harrell Jr","year":"2001","unstructured":"Harrell FE Jr (2001) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer, New York, pp 60\u201361"},{"key":"2419_CR2","doi-asserted-by":"publisher","first-page":"e1571","DOI":"10.1212\/WNL.0000000000008979","volume":"94","author":"EM Arenaza-Urquijo","year":"2020","unstructured":"Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM et al (2020) Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults. Neurology 94:e1571\u2013e1579. https:\/\/doi.org\/10.1212\/WNL.0000000000008979","journal-title":"Neurology"},{"key":"2419_CR3","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N et al (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140:3286\u20133300. https:\/\/doi.org\/10.1093\/brain\/awx243","journal-title":"Brain"},{"key":"2419_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"2419_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4:7. https:\/\/doi.org\/10.1186\/s13742-015-0047-8","journal-title":"Gigascience"},{"key":"2419_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.tig.2019.02.005","volume":"35","author":"D Chasioti","year":"2019","unstructured":"Chasioti D, Yan J, Nho K, Saykin AJ (2019) Progress in polygenic composite scores in Alzheimer\u2019s and other complex diseases. Trends Genet 35:371\u2013382. https:\/\/doi.org\/10.1016\/j.tig.2019.02.005","journal-title":"Trends Genet"},{"key":"2419_CR7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","volume":"60","author":"CM Clark","year":"2003","unstructured":"Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D et al (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60:1696\u20131702. https:\/\/doi.org\/10.1001\/archneur.60.12.1696","journal-title":"Arch Neurol"},{"key":"2419_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923. https:\/\/doi.org\/10.1126\/science.8346443","journal-title":"Science"},{"key":"2419_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2017.08.013","volume":"14","author":"C Cruchaga","year":"2018","unstructured":"Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J et al (2018) Polygenic risk score of sporadic late-onset Alzheimer\u2019s disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205\u2013214. https:\/\/doi.org\/10.1016\/j.jalz.2017.08.013","journal-title":"Alzheimers Dement"},{"key":"2419_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","volume":"78","author":"C Cruchaga","year":"2013","unstructured":"Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM et al (2013) GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease. Neuron 78:256\u2013268. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.026","journal-title":"Neuron"},{"key":"2419_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Schonherr S, Sidore C, Locke AE, Kwong A et al (2016) Next-generation genotype imputation service and methods. Nat Genet 48:1284\u20131287. https:\/\/doi.org\/10.1038\/ng.3656","journal-title":"Nat Genet"},{"key":"2419_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K et al (2017) Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol 133:839\u2013856. https:\/\/doi.org\/10.1007\/s00401-017-1685-y","journal-title":"Acta Neuropathol"},{"key":"2419_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002258","volume":"14","author":"RS Desikan","year":"2017","unstructured":"Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA et al (2017) Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med 14:e1002258. https:\/\/doi.org\/10.1371\/journal.pmed.1002258","journal-title":"PLoS Med"},{"key":"2419_CR14","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E et al (2015) Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain 138:3673\u20133684. https:\/\/doi.org\/10.1093\/brain\/awv268","journal-title":"Brain"},{"key":"2419_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s004010051163","volume":"99","author":"G Gold","year":"2000","unstructured":"Gold G, Bouras C, Kovari E, Canuto A, Glaria BG, Malky A et al (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99:579\u2013582. https:\/\/doi.org\/10.1007\/s004010051163","journal-title":"Acta Neuropathol"},{"key":"2419_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA et al (2019) Association of amyloid and tau with cognition in preclinical alzheimer disease: a longitudinal study. JAMA Neurol 76:915\u2013924. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1424","journal-title":"JAMA Neurol"},{"issue":"4","key":"2419_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/alz.12406","volume":"18","author":"ACV Harten","year":"2021","unstructured":"Harten ACV, Wiste HJ, Weigand SD, Mielke MM, Kremers WK, Eichenlaub U et al (2021) Detection of Alzheimer\u2019s disease using elecsys amyloid-Beta 1\u201342, P-Tau, and T-Tau assays. Alzheimers Dement 18(4):635\u2013644","journal-title":"Alzheimers Dement"},{"key":"2419_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","volume":"31","author":"JE Hixson","year":"1990","unstructured":"Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545\u2013548","journal-title":"J Lipid Res"},{"key":"2419_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","volume":"75","author":"TJ Hohman","year":"2018","unstructured":"Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B et al (2018) Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol 75:989\u2013998. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0821","journal-title":"JAMA Neurol"},{"key":"2419_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"2419_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL et al (2018) Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s Disease. Neuroimage Clin 17:452\u2013464. https:\/\/doi.org\/10.1016\/j.nicl.2017.09.016","journal-title":"Neuroimage Clin"},{"key":"2419_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"2419_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216. https:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0","journal-title":"Lancet Neurol"},{"key":"2419_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1971","author":"CR Jack Jr","year":"2019","unstructured":"Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P et al (2019) Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the national institute on aging-Alzheimer\u2019s association research framework. JAMA Neuro. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1971","journal-title":"JAMA Neuro"},{"key":"2419_CR25","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1001\/jama.2019.7437","volume":"321","author":"CR Jack Jr","year":"2019","unstructured":"Jack CR Jr, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM et al (2019) Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia. JAMA 321:2316\u20132325. https:\/\/doi.org\/10.1001\/jama.2019.7437","journal-title":"JAMA"},{"key":"2419_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","volume":"16","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V et al (2017) Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study. Lancet Neurol 16:435\u2013444. https:\/\/doi.org\/10.1016\/S1474-4422(17)30077-7","journal-title":"Lancet Neurol"},{"key":"2419_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS et al (2017) Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement 13:205\u2013216. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.005","journal-title":"Alzheimers Dement"},{"key":"2419_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319. https:\/\/doi.org\/10.1002\/ana.20009","journal-title":"Ann Neurol"},{"key":"2419_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT et al (2021) Alzheimer disease. Nat Rev Dis Primers 7:33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Primers"},{"key":"2419_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jamaneurol.2020.3921","volume":"78","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Lundt ES, Therneau TM, Albertson SM, Gunter JL, Senjem ML et al (2021) Association of initial beta-amyloid levels with subsequent flortaucipir positron emission tomography changes in persons without cognitive impairment. JAMA Neurol 78:217\u2013228. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3921","journal-title":"JAMA Neurol"},{"key":"2419_CR31","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/brain\/awz025","volume":"142","author":"DS Knopman","year":"2019","unstructured":"Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K et al (2019) Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects. Brain 142:1148\u20131160. https:\/\/doi.org\/10.1093\/brain\/awz025","journal-title":"Brain"},{"key":"2419_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51:414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nat Genet"},{"key":"2419_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J et al (2020) Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aau5732","journal-title":"Sci Transl Med"},{"key":"2419_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"2419_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.25530","volume":"86","author":"G Leonenko","year":"2019","unstructured":"Leonenko G, Shoai M, Bellou E, Sims R, Williams J, Hardy J et al (2019) Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol 86:427\u2013435. https:\/\/doi.org\/10.1002\/ana.25530","journal-title":"Ann Neurol"},{"key":"2419_CR36","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E et al (2019) Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry 24:1112\u20131134. https:\/\/doi.org\/10.1038\/s41380-018-0342-8","journal-title":"Mol Psychiatry"},{"key":"2419_CR37","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1212\/WNL.0000000000007728","volume":"93","author":"VJ Lowe","year":"2019","unstructured":"Lowe VJ, Bruinsma TJ, Wiste HJ, Min HK, Weigand SD, Fang P et al (2019) Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults. Neurology 93:e29\u2013e39. https:\/\/doi.org\/10.1212\/WNL.0000000000007728","journal-title":"Neurology"},{"key":"2419_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF et al (2018) Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia. Brain 141:271\u2013287. https:\/\/doi.org\/10.1093\/brain\/awx320","journal-title":"Brain"},{"key":"2419_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A et al (2016) A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48:1279\u20131283. https:\/\/doi.org\/10.1038\/ng.3643","journal-title":"Nat Genet"},{"key":"2419_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hbm.25311","volume":"43","author":"SE Medland","year":"2022","unstructured":"Medland SE, Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J et al (2022) Ten years of enhancing neuro-imaging genetics through meta-analysis: An overview from the ENIGMA Genetics Working Group. Hum Brain Mapp 43:292\u2013299. https:\/\/doi.org\/10.1002\/hbm.25311","journal-title":"Hum Brain Mapp"},{"key":"2419_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ et al (2018) Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14:989\u2013997. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.013","journal-title":"Alzheimers Dement"},{"key":"2419_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jalz.2019.07.009","volume":"15","author":"MM Mielke","year":"2019","unstructured":"Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Vemuri P et al (2019) Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin. Alzheimers Dement 15:1437\u20131447. https:\/\/doi.org\/10.1016\/j.jalz.2019.07.009","journal-title":"Alzheimers Dement"},{"key":"2419_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"2419_CR44","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW et al (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73. https:\/\/doi.org\/10.7326\/M14-0698","journal-title":"Ann Intern Med"},{"key":"2419_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V et al (2018) High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease. Nature 554:249\u2013254. https:\/\/doi.org\/10.1038\/nature25456","journal-title":"Nature"},{"key":"2419_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ et al (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362\u2013381. https:\/\/doi.org\/10.1097\/NEN.0b013e31825018f7","journal-title":"J Neuropathol Exp Neurol"},{"key":"2419_CR47","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139:1551\u20131567. https:\/\/doi.org\/10.1093\/brain\/aww027","journal-title":"Brain"},{"key":"2419_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1212\/WNL.0000000000006088","volume":"91","author":"RC Petersen","year":"2018","unstructured":"Petersen RC (2018) How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture. Neurology 91:395\u2013402. https:\/\/doi.org\/10.1212\/WNL.0000000000006088","journal-title":"Neurology"},{"key":"2419_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1212\/WNL.0b013e3181f11d85","volume":"75","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS et al (2010) Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 75:889\u2013897. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f11d85","journal-title":"Neurology"},{"key":"2419_CR50","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904\u2013909. https:\/\/doi.org\/10.1038\/ng1847","journal-title":"Nat Genet"},{"key":"2419_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.13909","volume":"2","author":"VK Ramanan","year":"2019","unstructured":"Ramanan VK, Castillo AM, Knopman DS, Graff-Radford J, Lowe VJ, Petersen RC et al (2019) Association of apolipoprotein E varepsilon4, educational level, and sex with tau deposition and tau-mediated metabolic dysfunction in older adults. JAMA Netw Open 2:e1913909. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.13909","journal-title":"JAMA Netw Open"},{"key":"2419_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-021-01154-1","volume":"9","author":"VK Ramanan","year":"2021","unstructured":"Ramanan VK, Lesnick TG, Przybelski SA, Heckman MG, Knopman DS, Graff-Radford J et al (2021) Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer\u2019s pathophysiology. Acta Neuropathol Commun 9:48. https:\/\/doi.org\/10.1186\/s40478-021-01154-1","journal-title":"Acta Neuropathol Commun"},{"key":"2419_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa159","author":"VK Ramanan","year":"2020","unstructured":"Ramanan VK, Wang X, Przybelski SA, Raghavan S, Heckman MG, Batzler A et al (2020) Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaa159","journal-title":"Brain Commun"},{"key":"2419_CR54","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W et al (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 106:6820\u20136825. https:\/\/doi.org\/10.1073\/pnas.0900345106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2419_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000115751","volume":"30","author":"RO Roberts","year":"2008","unstructured":"Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF et al (2008) The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30:58\u201369. https:\/\/doi.org\/10.1159\/000115751","journal-title":"Neuroepidemiology"},{"key":"2419_CR56","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/WNL.0000000000004652","volume":"89","author":"RO Roberts","year":"2017","unstructured":"Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK et al (2017) Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers. Neurology 89:2039\u20132048. https:\/\/doi.org\/10.1212\/WNL.0000000000004652","journal-title":"Neurology"},{"key":"2419_CR57","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","volume":"87","author":"WA Rocca","year":"2012","unstructured":"Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd (2012) History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 87:1202\u20131213. https:\/\/doi.org\/10.1016\/j.mayocp.2012.08.012","journal-title":"Mayo Clin Proc"},{"key":"2419_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12:19. https:\/\/doi.org\/10.1186\/s13024-017-0162-3","journal-title":"Mol Neurodegener"},{"key":"2419_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W et al (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549:523\u2013527. https:\/\/doi.org\/10.1038\/nature24016","journal-title":"Nature"},{"key":"2419_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.brainresbull.2018.03.013","volume":"140","author":"K Singh","year":"2018","unstructured":"Singh K, Lillevali K, Gilbert SF, Bregin A, Narvik J, Jayaram M et al (2018) The combined impact of IgLON family proteins Lsamp and Neurotrimin on developing neurons and behavioral profiles in mouse. Brain Res Bull 140:5\u201318. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.03.013","journal-title":"Brain Res Bull"},{"key":"2419_CR61","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/ije\/dys195","volume":"41","author":"JL St Sauver","year":"2012","unstructured":"St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Pankratz JJ, Brue SM et al (2012) Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 41:1614\u20131624. https:\/\/doi.org\/10.1093\/ije\/dys195","journal-title":"Int J Epidemiol"},{"key":"2419_CR62","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awy327","volume":"142","author":"CH Tan","year":"2019","unstructured":"Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ et al (2019) Polygenic hazard score, amyloid deposition and Alzheimer\u2019s neurodegeneration. Brain 142:460\u2013470. https:\/\/doi.org\/10.1093\/brain\/awy327","journal-title":"Brain"},{"key":"2419_CR63","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1212\/WNL.0000000000011416","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault J, Pascoal TA, Benedet AL, Tissot C, Savard M, Chamoun M et al (2021) Frequency of biologically defined Alzheimer disease in relation to age, sex, APOE epsilon4, and cognitive impairment. Neurology 96:e975\u2013e985. https:\/\/doi.org\/10.1212\/WNL.0000000000011416","journal-title":"Neurology"},{"key":"2419_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L et al (2020) Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat Med 26:387\u2013397. https:\/\/doi.org\/10.1038\/s41591-020-0762-2","journal-title":"Nat Med"},{"key":"2419_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa068","author":"RA Townley","year":"2020","unstructured":"Townley RA, Graff-Radford J, Mantyh WG, Botha H, Polsinelli AJ, Przybelski SA et al (2020) Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaa068","journal-title":"Brain Commun"},{"key":"2419_CR66","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1534\/genetics.114.164285","volume":"197","author":"G Tucker","year":"2014","unstructured":"Tucker G, Price AL, Berger B (2014) Improving the power of GWAS and avoiding confounding from population stratification with PC-Select. Genetics 197:1045\u20131049. https:\/\/doi.org\/10.1534\/genetics.114.164285","journal-title":"Genetics"},{"key":"2419_CR67","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1212\/WNL.0000000000009874","volume":"95","author":"AC Van Harten","year":"2020","unstructured":"Van Harten AC, Wiste HJ, Weigand SD, Mielke MM, Kremers WK, Eichenlaub U et al (2020) CSF biomarkers in Olmsted County: evidence of 2 subclasses and associations with demographics. Neurology 95:e256\u2013e267. https:\/\/doi.org\/10.1212\/WNL.0000000000009874","journal-title":"Neurology"},{"key":"2419_CR68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.25071","volume":"82","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J et al (2017) Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Ann Neurol 82:706\u2013718. https:\/\/doi.org\/10.1002\/ana.25071","journal-title":"Ann Neurol"},{"key":"2419_CR69","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jamaneurol.2014.963","volume":"71","author":"P Vemuri","year":"2014","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Machulda M, Knopman DS, Mielke MM et al (2014) Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol 71:1017\u20131024. https:\/\/doi.org\/10.1001\/jamaneurol.2014.963","journal-title":"JAMA Neurol"},{"key":"2419_CR70","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ana.21953","volume":"67","author":"P Vemuri","year":"2010","unstructured":"Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ et al (2010) Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol 67:308\u2013316. https:\/\/doi.org\/10.1002\/ana.21953","journal-title":"Ann Neurol"},{"key":"2419_CR71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","volume":"14","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC (2015) Tau imaging: early progress and future directions. Lancet Neurol 14:114\u2013124. https:\/\/doi.org\/10.1016\/S1474-4422(14)70252-2","journal-title":"Lancet Neurol"},{"key":"2419_CR72","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA (2019) Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. Ann Neurol 85:726\u2013739. https:\/\/doi.org\/10.1002\/ana.25455","journal-title":"Ann Neurol"},{"key":"2419_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/alz.12173","volume":"17","author":"AJ Weigand","year":"2021","unstructured":"Weigand AJ, Thomas KR, Bangen KJ, Eglit GML, Delano-Wood L, Gilbert PE et al (2021) APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia. Alzheimers Dement 17:61\u201369. https:\/\/doi.org\/10.1002\/alz.12173","journal-title":"Alzheimers Dement"},{"key":"2419_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41380-018-0246-7","volume":"26","author":"Q Yan","year":"2021","unstructured":"Yan Q, Nho K, Del-Aguila JL, Wang X, Risacher SL, Fan KH et al (2021) Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry 26:309\u2013321. https:\/\/doi.org\/10.1038\/s41380-018-0246-7","journal-title":"Mol Psychiatry"},{"key":"2419_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-020-00754-8","volume":"13","author":"A Zettergren","year":"2021","unstructured":"Zettergren A, Lord J, Ashton NJ, Benedet AL, Karikari TK, Lantero Rodriguez J et al (2021) Association between polygenic risk score of Alzheimer\u2019s disease and plasma phosphorylated tau in individuals from the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimers Res Ther 13:17. https:\/\/doi.org\/10.1186\/s13195-020-00754-8","journal-title":"Alzheimers Res Ther"},{"key":"2419_CR76","doi-asserted-by":"publisher","first-page":"136","DOI":"10.21037\/atm.2016.03.35","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z (2016) Variable selection with stepwise and best subset approaches. Ann Transl Med 4:136. https:\/\/doi.org\/10.21037\/atm.2016.03.35","journal-title":"Ann Transl Med"},{"key":"2419_CR77","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Linares C, Kurti A, Knight JA et al (2018) APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat Commun 9:4388. https:\/\/doi.org\/10.1038\/s41467-018-06783-0","journal-title":"Nat Commun"},{"key":"2419_CR78","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","volume":"28","author":"X Zheng","year":"2012","unstructured":"Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS (2012) A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 28:3326\u20133328. https:\/\/doi.org\/10.1093\/bioinformatics\/bts606","journal-title":"Bioinformatics"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-022-02419-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T14:06:37Z","timestamp":1650895597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-022-02419-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2419"],"URL":"https:\/\/doi.org\/10.1007\/s00401-022-02419-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Vemuri received speaker fees from Miller Medical Communications, Inc. and receives research support from the NIH. Dr. Graff-Radford serves as an assistant editor for Neurology and receives research support from the NIH. Dr. Lowe consults for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals and the NIH. Dr. Murray served as a consultant for AVID Radiopharmaceuticals. Dr. Mielke serves as a consultant for Biogen and Brain Protection Company and receives research funds from the NIH and DOD. Dr. Machulda receives research support from NIH. Dr. Petersen serves as a consultant for Roche Inc., Merck Inc., and Biogen, Inc., serves on the Data Safety Monitoring Board for Genentech, Inc., and receives a royalty from Oxford University Press and UpToDate. Dr. Knopman serves on a Data Safety Monitoring Board for the DIAN study, serves on a Data Safety Monitoring Board for Biogen but receives no personal compensation, is an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals, and the University of Southern California, and serves as a consultant for Roche, Samus Therapeutics, Third Rock and Alzeca Biosciences but receives no personal compensation. Dr. Jack serves on an independent data monitoring board for Roche, has served as a speaker for Eisai, and consulted for Biogen, but he receives no personal compensation from any commercial entity. He receives research support from NIH and the Alexander Family Alzheimer\u2019s Disease Research Professorship of the Mayo Clinic. The remaining authors report no relevant financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}